How to buy Regeneron Pharmaceuticals shares

Regeneron Pharmaceuticals shares have fallen -0.79% from yesterday's closing price ($831.62). Learn how to easily invest in Regeneron Pharmaceuticals shares in the UK.

Regeneron Pharmaceuticals Inc (REGN) is a publicly traded biotechnology business based in the US. It opened the day at $829.92 after a previous close of $831.62. During the day the price has varied from a low of $817.5 to a high of $832.15. The latest price was $825.03 (25 minute delay). Regeneron Pharmaceuticals is listed on the NASDAQ and employs 12,256 staff. All prices are listed in US Dollars.

How to buy shares in Regeneron Pharmaceuticals

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: REGN in this case.
  5. Research Regeneron Pharmaceuticals shares. The platform should provide the latest information available.
  6. Buy your Regeneron Pharmaceuticals shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy Regeneron Pharmaceuticals shares:

Best for

Beginner investments

IG Share Dealing image

Fees for buying 5x Regeneron Pharmaceuticals shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Customer rating Platform fee Min. initial deposit Trading fee estimate
Freetrade logo ★★★★★ £0 - £9.99 No minimum £19.78
£3,372.29 total
Capital at risk
eToro Free Stocks logo ★★★★★ £0 $50 £16.76
£3,369.27 total
Capital at risk
IG Share Dealing logo ★★★★★ £0 £250 £24.93
£3,377.44 total
Capital at risk
XTB logo Not yet rated £0 No minimum £16.76
£3,369.27 total
Capital at risk
CMC Invest share dealing account logo Not yet rated £0 No minimum £16.76
£3,369.27 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo ★★★★★ £0 £1 £45.48
£3,397.98 total
Capital at risk
Lightyear logo Not yet rated £0 No minimum £11.82
£3,364.32 total
Capital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in Regeneron Pharmaceuticals

Is it a good time to buy Regeneron Pharmaceuticals stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks

Invest in Regeneron Pharmaceuticals shares

  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Regeneron Pharmaceuticals under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Regeneron Pharmaceuticals P/E ratio, PEG ratio and EBITDA

Regeneron Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Regeneron Pharmaceuticals shares trade at around 22x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Regeneron Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 9.0135. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Regeneron Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Regeneron Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $4.8 billion (£3.9 billion).

The EBITDA is a measure of a Regeneron Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

What's Regeneron Pharmaceuticals's ESG track record?

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Regeneron Pharmaceuticals.

Overall Regeneron Pharmaceuticals ESG score

Regeneron Pharmaceuticals's total ESG risk: 22.33

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Regeneron Pharmaceuticals's overall score of 22.33 (as at 01/01/2019) is pretty good – landing it in it in the 27th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Regeneron Pharmaceuticals is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Regeneron Pharmaceuticals's environmental score: 1.51/100

Regeneron Pharmaceuticals's environmental score of 1.51 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Regeneron Pharmaceuticals is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Regeneron Pharmaceuticals's social score: 13.94/100

Regeneron Pharmaceuticals's social score of 13.94 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Regeneron Pharmaceuticals is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Regeneron Pharmaceuticals's governance score: 5.88/100

Regeneron Pharmaceuticals's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Regeneron Pharmaceuticals is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Regeneron Pharmaceuticals's controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Regeneron Pharmaceuticals scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Regeneron Pharmaceuticals has, for the most part, managed to keep its nose clean.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

  • How to buy Exelixis shares

    Ever wondered how to buy shares in Exelixis? We explain how and compare a range of providers that can give you access to many brands, including Exelixis.

  • How to buy Five Star Senior Living shares

    Ever wondered how to buy shares in Five Star Senior Living? We explain how and compare a range of providers that can give you access to many brands, including Five Star Senior Living.

  • How to buy Community Health Systems shares

    Ever wondered how to buy shares in Community Health Systems? We explain how and compare a range of providers that can give you access to many brands, including Community Health Systems.

  • How to buy Chiasma shares

    Ever wondered how to buy shares in Chiasma? We explain how and compare a range of providers that can give you access to many brands, including Chiasma.

  • How to buy Healthcare Services Group shares

    Ever wondered how to buy shares in Healthcare Services Group? We explain how and compare a range of providers that can give you access to many brands, including Healthcare Services Group.

  • How to buy Catalent shares

    Ever wondered how to buy shares in Catalent? We explain how and compare a range of providers that can give you access to many brands, including Catalent.

  • How to buy Aytu BioScience shares

    Ever wondered how to buy shares in Aytu BioScience? We explain how and compare a range of providers that can give you access to many brands, including Aytu BioScience.

  • How to buy bluebird bio shares

    Ever wondered how to buy shares in bluebird bio? We explain how and compare a range of providers that can give you access to many brands, including bluebird bio.

  • How to buy LHC Group shares

    Ever wondered how to buy shares in LHC Group? We explain how and compare a range of providers that can give you access to many brands, including LHC Group.

  • How to buy Amneal Pharmaceuticals shares

    Ever wondered how to buy shares in Amneal Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Amneal Pharmaceuticals.

Go to site